Collective Media, a New York-based provider of an online advertising network, has raised $20 million in Series B funding. Accel Partners led the round, and was joined by return backer iNovia Capital. Past backer Greycroft Partners was not noted in the press release.
4 min read · 13 April 2009
Goldman Sachs has closed its fifth secondaries fund with approximately $5.5 billion in capital commitments. Its previous secondaries fund closed in 2006 with $3 billion.
2 min read · 13 April 2009
Molecular Templates Inc., an Austin, Texas-based biotech company with a protein platform for developing cancer therapeutics, has raised $2.5 million from Santé Ventures.
2 min read · 13 April 2009
Nuventix Inc., an Austin, Texas-based developer of thermal management solutions, has raised $4 million in additional Series C funding from Braemar Energy Ventures ($3m) and Korea’s Uniquest ($1m). The round now stands at $18 million. Braemar had participated on the first close, alongside ATV, CenterPoint Ventures, InterWest Partners and Rho Ventures. Nuventix also has secured a new $4 million line of credit from Silicon Valley Bank.
3 min read · 13 April 2009
Adapx, a Seattle-based maker of digital pens and paper, has raised $9 million in second-round funding. UV Partners led the round, and was joined by OVP Venture Partners and Paladin Capital Group. The company previously raised money from In-Q-Tel, the venture capital arm of the CIA.
4 min read · 12 April 2009
1 min read · 10 April 2009
1 min read · 10 April 2009
1 min read · 10 April 2009
Marinus Pharmaceuticals Inc., a Branford, Conn.-based developer of neurological and psychiatric drugs, has raised $20 million in Series B funding. Return backers include Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners. The company's lead candidate is for adults who suffer from partial onset seizures.
5 min read · 10 April 2009
Cell Biosciences, a Palo Alto, Calif.-based provider of nanoproteomic analysis systems to life science researchers, has raised $10 million in Series C funding. The Wellcome Trust led the round, and was joined by return backers Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada and The Vertical Group.
2 min read · 10 April 2009
